1. Home
  2. EEFT vs IMNM Comparison

EEFT vs IMNM Comparison

Compare EEFT & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Euronet Worldwide Inc.

EEFT

Euronet Worldwide Inc.

N/A

Current Price

$68.02

Market Cap

3.2B

Sector

Technology

ML Signal

N/A

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$20.31

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EEFT
IMNM
Founded
1994
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
EEFT
IMNM
Price
$68.02
$20.31
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$96.00
$32.80
AVG Volume (30 Days)
592.5K
987.2K
Earning Date
04-23-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
6.05
51.40
EPS
6.84
N/A
Revenue
$4,244,200,000.00
$6,941,000.00
Revenue This Year
$8.27
$18.41
Revenue Next Year
$6.03
$863.23
P/E Ratio
$9.73
N/A
Revenue Growth
6.38
N/A
52 Week Low
$64.34
$5.15
52 Week High
$114.25
$27.65

Technical Indicators

Market Signals
Indicator
EEFT
IMNM
Relative Strength Index (RSI) 42.50 41.95
Support Level $67.82 $19.26
Resistance Level $75.93 $22.57
Average True Range (ATR) 2.24 1.09
MACD -0.49 -0.01
Stochastic Oscillator 25.97 19.86

Price Performance

Historical Comparison
EEFT
IMNM

About EEFT Euronet Worldwide Inc.

Euronet Worldwide Inc is a provider of electronic financial transaction solutions. It offers payment and transaction processing and distribution solutions to financial institutions, retailers, service providers, and individual consumers. The company's product offerings include comprehensive ATM, POS, card outsourcing, card issuing and merchant acquiring services, software solutions, money transfer services, etc. Its reportable operating segments are EFT Processing, epay, and Money Transfer. Maximum revenue is derived from its Money Transfer segment, which provides money transfer services across the world under the brand names Ria, AFEX, IME, and xe. Geographically, the company generates maximum revenue from the United States, followed by Germany, India, France, Greece, and other regions.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: